SAVA Q1 2019 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$574

Operating Income

-$1M

Net Income

-$1M

EPS (Diluted)

$-0.08

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$604,000

Free Cash Flow

-$622,000

Stock-Based Comp.

$344,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$970,000

Stockholders' Equity

$19M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$574	-$1,068	+46.3%
Operating Income	-$1M	-$2M	+33.0%
Net Income	-$1M	-$2M	+37.1%